BioCatalystWatch
SIGAWorkspace / SIGA / OverviewCompany library
SIGA TECHNOLOGIES INC logo

SIGA TECHNOLOGIES INC

SIGA TECHNOLOGIES INC (SIGA)

Website

Featured programme · TPOXX pediatric formulation

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

TPOXX pediatric formulation

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

TPOXX pediatric formulation

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

TPOXX

Upcoming / outlook

Approved / commercial

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved
TPOXX

PreINDP1P2P3FilingApproved
TPOXX

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

History / paused

VP37

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

SIGA PR & News

PR & News

SIGA SEC archive